Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: Amgen, Tokyo Electron and Kinross Gold

Read MoreHide Full Article

For Immediate Release

Chicago, IL – September 17, 2019 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Amgen (AMGN - Free Report) , Tokyo Electron (TOELY - Free Report) and Kinross Gold (KGC - Free Report) .

Here are highlights from Monday’s Analyst Blog:

Why Cut the Fed Funds Rate Again: Global Week Ahead

 This is a Fed meeting week. On Wednesday, Fed Chair Powell is widely anticipated to cut the Fed Funds rate another 25 basis points.

With a U.S. consensus forecast for a tad above 2.0% U.S. real GDP growth rate, a core U.S. CPI tracking near +2.0% in y/y terms, and a U.S. 3.7% household unemployment rate, the Fed’s statutory mandate of stable consumer prices and full employment is clearly and succinctly met.

For this economist, it is hard to say what is the real justification.

It could be to keep policy and risk-free benchmark U.S. Treasury rates in alignment with the ECB’s easing last week. It could be to alleviate trade war uncertainty. It could be to assist in next year’s U.S. Presidential election.

Most likely, it is all of the above. I placed them in order of their likely emphasis, too.

Next, I have Reuters’ five world market themes for the Global Week Ahead, leaving them in order of importance for equity market traders. Yes: the Fed Meeting leads. But don’t forget about the many central bank meetings that conclude the following day.

(1) The Fed Meets Tuesday and Wednesday

Investors around the globe are bracing for a second rate cut from the U.S. Federal Reserve at its policy-setting Federal Open Market Committee on Sept. 17-18.

Fed Chair Jerome Powell recently said that the central bank remained committed to keeping the U.S. economic expansion going, signaling he and his colleagues are likely to cut interest rates into 2020. But even so, President Donald Trump has made life a little harder for Powell.

Trump again lambasted the Fed following an European Central Bank rate cut Thursday that sent the euro lower, tweeting the ECB was “succeeding” in “depreciating the Euro against the VERY strong Dollar, hurting U.S. exports” while the Fed “sits, and sits, and sits.”

Powell acknowledged “a range of views” among policymakers; his careful wording reflects a split within the U.S. central bank about how best to respond to an economy where the job market and consumer spending are holding up but trade tensions between Beijing and Washington, Britain’s possibly messy exit from the European Union and a broad global slowdown pose risks.

The Fed cut rates for the first time in more than a decade in July. Market pricing suggests that investors expect another quarter-point reduction next week.

(2) Lots of Central Banks Will Follow Suit Thursday

After the European Central Bank’s bazooka, the wait is on to see what the message is from other central banks. The Fed of course will cut rates by a quarter point on Wednesday. But Thursday brings policy meetings in Japan, Britain, Norway and Switzerland.

The Bank of Japan, sources say, will discuss further easing; it may even decide to act to head off further economic pain, a third of analysts in a Reuters poll predict. Upcoming trade and inflation data should show Japan’s export slump deepening and inflation at two-year lows. But its dilemma is the same as elsewhere: How to inject stimulus without hurting banks any further, and how to make it effective?

Switzerland, with a -0.75% interest rate, is quiet so far on the prospect of emulating ECB easing but will be concerned at the franc’s surge to two-year highs versus the euro. On the other hand, the relentless rise in SNB “sight deposits” is hardly tenable: These are at almost 600 billion francs as the SNB intervenes to tamp down the franc.

Brexit clouds the Bank of England’s strategy but Norway, one of very few central banks still pressing on with rate rises, could hike again on Sept. 19. But with easing gathering steam all around, it is very likely to mark the end of its tightening cycle.

There is excitement also in emerging markets, where Brazil is expected to cut 50 bps on Wednesday. South Africa’s central bank also meets on Thursday, though is not expected to move. But these days, you never know.

(3) Can a Mini Trade Deal Be Struck in October?

Financial markets were quick to seize on recent conciliatory messages and measures between Beijing and Washington as a hopeful sign of an imminent deal in the protracted trade war. Yet that may be as much a symptom of fatigue — from the unremitting tweets and retorts — as genuine optimism.

A Reuters poll of 60 economists shows 80% expect relations between Beijing and the Trump administration to deteriorate or at best hold steady until end-2020.

The week saw Beijing exempt some agricultural products from additional tariffs on U.S. goods and Trump delay a tariff increase on certain Chinese goods by two weeks. Junior U.S. and Chinese officials meet in the coming week, followed by talks between senior trade negotiators in early October.

Meanwhile, the IMF has issued dire warnings of a drop in global economic growth next year. China’s neighbors are seeing growth rates slide as their exports to the mainland collapse.

Some are looking for upsides: Vietnam has been a beneficiary of businesses seeking to move or alter trade routes. Thailand just announced a package of tax incentives, investment zones and new legislation that would draw in companies from China, Japan, Taiwan and South Korea. But if tensions are shrinking the world trade pie, any feasting in Southeast Asia may be short-lived.

China also reports industrial output and retails sales data for August on Monday.

(4) Brexit and Boris Johnson: The Same Issue

Britain’s never-ending Brexit drama is set to reach fever pitch again — this time in the country’s top court.

Prime Minister Boris Johnson will challenge a ruling of Scotland’s highest court of appeal that his decision to suspend, or prorogue, parliament for five weeks was unlawful and should be annulled. Gina Miller will appeal a rejection of her challenge for a judicial review of Johnson’s decision to prorogue parliament. Both cases are scheduled to be heard by U.K.’s Supreme Court on Tuesday.

Proroguing parliament until Oct. 14 was seen by most as a tactical move from Johnson to make sure he maintains a strong negotiating hand with Brussels.

Johnson wanted to show he can deliver a no-deal Brexit on Oct. 31. Most investors believed him, sending the pound sharply lower at the start of the month, to levels not seen since 1985.

But the tables seem to have turned for now: Parliament managed to pass a law that forces Johnson to extend Brexit if a deal isn’t reached by Oct. 19. Traders say this has definitely reduced the probability of a no-deal Brexit on Oct. 31, though the risks of a no-deal Brexit down the road was still high.

(5) Will Emerging Markets Finally Be the Place to Be?

If the Fed goes big with its rate cut on Wednesday, the place to be will probably be the riskier parts of the world that still have interest rates you can see with the naked eye.

Low rates in the United States and sub-zero ones in core Europe and Japan mean high-yield bonds from places like Turkey, Ukraine, Ecuador, Egypt, Brazil or parts of sub-Saharan Africa look ever more attractive.

There is a catch-up factor in play too. August was a torrid month for these countries’ assets. Argentina’s slump into crisis made it worse, of course, but the underperformance between high-yield emerging market sovereign debt and that the safer ‘investment grade’ (IG) emerging market countries, was one of the most severe ever — roughly -3% returns versus +3% for IG emerging markets debt.

Turkey’s jumbo rate cut this week helped speed that catch up process but a dove-bomb from the Fed on Wednesday as well as a big chop from Brazil and more soothing trade war sounds will all help it along nicely.

Top Zacks #1 Rank Stocks

Amgen: Health Care stocks have been overlooked in this rally. So far. This Zacks #1 Rank stock has a Zacks Value Score of B and a Growth score of D.

(2) Tokyo Electron: Japanese stocks have rallied recently. This premier chip stock is no exception. This is a $32B market cap stock with a $48 share price. It carries a Zacks Value Score of D and Growth Score of D.

(3) Kinross Gold: This is a $5.9B market cap gold miner, whose shares trade at $4.72. The Zacks Value Score is A, the Growth Score is A, and the Momentum Score is A.

What’s wrong with that? Nothing, other than the price of gold may have already run up, and all the good news is fully priced in. As a cheap stock, though, there may be more to go.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339                                                                            

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Amgen Inc. (AMGN) - free report >>

Kinross Gold Corporation (KGC) - free report >>

Tokyo Electron Ltd. (TOELY) - free report >>